Expertise in
50
conditions

Dr. Benjamin R. Nadeau

Oncology
Tennessee Oncology
605 Glenwood Dr Ste 200, 
Chattanooga, TN 
Accepting New Patients
Offers Telehealth
Expertise in
50
conditions
Tennessee Oncology
605 Glenwood Dr Ste 200, 
Chattanooga, TN 

Overview

Benjamin Nadeau is an Oncologist practicing medicine in Chattanooga, Tennessee.

Dr. Nadeau is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer.

He is actively involved in clinical research, participating in 2 clinical trials. Dr. Nadeau is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TN

Hospital Affiliations

Memorial Healthcare System, Inc
Parkridge Medical Center
Erlanger Medical Center

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Tennessee Oncology
605 Glenwood Dr Ste 200, Chattanooga, TN 37404

Additional Areas of Focus

Dr. Nadeau has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Expertise in
60
conditions
Expertise in
60
conditions
Referral may be required

Tennessee Oncology

605 Glenwood Dr Ste 200, 
Chattanooga, TN 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Davey Daniel is an Oncologist practicing medicine in Chattanooga, Tennessee. Dr. Daniel is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Renal Cell Carcinoma (RCC). Dr. Daniel is currently accepting new patients.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

Tennessee Oncology

605 Glenwood Dr Ste 200, 
Chattanooga, TN 
 (0.1 miles away)
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Brooke Daniel is an Oncologist practicing medicine in Chattanooga, Tennessee. Dr. Daniel is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Daniel is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Chattanooga Program In Women's Oncology

102 Central Ave, 
Chattanooga, TN 
 (1.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Depasquale is an Oncologist practicing medicine in Chattanooga, Tennessee. Dr. Depasquale is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Ureteroscopy, and Hernia Surgery. Dr. Depasquale is currently accepting new patients.

Frequently Asked Questions about Dr. Benjamin R. Nadeau

Is Dr. Benjamin R. Nadeau a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benjamin R. Nadeau is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Benjamin R. Nadeau specialize in?

While Dr. Benjamin R. Nadeau is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Benjamin R. Nadeau accept my insurance?

Dr. Benjamin R. Nadeau accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nadeau's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 41 Advanced Conditions
    View All 104 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile